Metformin MET
MET
0.00003724
$
10.08 %
Change 24h
Market Cap
$ 37,383
Volume 24h
$ 260.15
Circulating Supply
999,683,993
Total Supply
999,999,369
MET
$
| # | Exchange | Pair | Price | Volume 24h |
|---|
Description
Our team of three experienced medical doctors, with a strong track record of publications in high-impact SCI and SCI-Expanded journals, is embarking on an ambitious research project to investigate the longevity benefits of metformin.
Metformin, widely recognized for its efficacy in managing type 2 diabetes, has drawn growing interest for its potential to influence aging and chronic disease pathways. Preclinical and clinical studies suggest that metformin may play a pivotal role in modulating mechanisms associated with aging, opening new avenues for research in longevity science.